Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2013, April) Reactions Weekly Vol. 1449 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2013 (April)Volume1449
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13302110Long-form Identifiermindat:1:5:13302110:5
GUID0
Full Reference(2013, April) Reactions Weekly Vol. 1449 (1) Springer Science and Business Media LLC
Plain Text(2013, April) Reactions Weekly Vol. 1449 (1) Springer Science and Business Media LLC
In(2013) Reactions Weekly Vol. 1449. Springer Science and Business Media LLC

Contains

(2013) Statin neurotoxicity visualised in bioassay. Reactions Weekly, 1449 (1) 1 doi:10.1007/s40278-013-2636-6
(2013) Amiodarone use associated with incident cancer in males. Reactions Weekly, 1449 (1) 2 doi:10.1007/s40278-013-2637-5
(2013) Further evidence rejects link between vaccines and autism. Reactions Weekly, 1449 (1) 2 doi:10.1007/s40278-013-2638-4
(2013) Acute liver injury not causally linked to orlistat. Reactions Weekly, 1449 (1) 2 doi:10.1007/s40278-013-2639-3
(2013) TNF inhibitors increase malignant melanoma risk. Reactions Weekly, 1449 (1) 3 doi:10.1007/s40278-013-2640-x
(2013) Submicron NSAIDs promise effective pain relief at low doses. Reactions Weekly, 1449 (1) 3 doi:10.1007/s40278-013-2641-9
(2013) FDA continues to uncover concerning compounding practices. Reactions Weekly, 1449 (1) 3 doi:10.1007/s40278-013-2642-8
(2013) Dextropropoxyphene meds to remain on Australian register. Reactions Weekly, 1449 (1) 4 doi:10.1007/s40278-013-2643-7
(2013) FDA recognises OxyContin's abuse-deterrent properties. Reactions Weekly, 1449 (1) 4 doi:10.1007/s40278-013-2644-6
(2013) Australia, NZ adopt joint approach for evaluation of OTC meds. Reactions Weekly, 1449 (1) 4 doi:10.1007/s40278-013-2645-5
(2013) Japan MHLW revises use of the term, `anaphylactoid symptoms'. Reactions Weekly, 1449 (1) 4 doi:10.1007/s40278-013-2646-4
(2013) MHRA warns of unlicensed aconite-containing herbal meds. Reactions Weekly, 1449 (1) 4 doi:10.1007/s40278-013-2647-3
(2013) Adefovir/lamivudine withdrawal. Reactions Weekly, 1449 (1) 5 doi:10.1007/s40278-013-2648-2
(2013) Acitretin. Reactions Weekly, 1449 (1) 5 doi:10.1007/s40278-013-2649-1
(2013) Allopurinol. Reactions Weekly, 1449 (1) 5 doi:10.1007/s40278-013-2650-8
(2013) Adalimumab. Reactions Weekly, 1449 (1) 5 doi:10.1007/s40278-013-2651-7
(2013) Antineoplastics. Reactions Weekly, 1449 (1) 6 doi:10.1007/s40278-013-2652-6
(2013) Amitriptyline overdose. Reactions Weekly, 1449 (1) 6 doi:10.1007/s40278-013-2653-5
(2013) Amiodarone. Reactions Weekly, 1449 (1) 6 doi:10.1007/s40278-013-2654-4
(2013) Amphotericin B liposomal. Reactions Weekly, 1449 (1) 6 doi:10.1007/s40278-013-2655-3
(2013) Asparaginase. Reactions Weekly, 1449 (1) 7 doi:10.1007/s40278-013-2656-2
(2013) Benzocaine. Reactions Weekly, 1449 (1) 7 doi:10.1007/s40278-013-2657-1
(2013) Atorvastatin. Reactions Weekly, 1449 (1) 7 doi:10.1007/s40278-013-2658-0
(2013) Aspirin. Reactions Weekly, 1449 (1) 7 doi:10.1007/s40278-013-2659-z
(2013) Buspirone. Reactions Weekly, 1449 (1) 8 doi:10.1007/s40278-013-2660-6
(2013) Bupropion/venlafaxine interaction. Reactions Weekly, 1449 (1) 8 doi:10.1007/s40278-013-2661-5
(2013) Bupivacaine/lidocaine/prilocaine. Reactions Weekly, 1449 (1) 8 doi:10.1007/s40278-013-2662-4
(2013) Cabergoline/ketorolac. Reactions Weekly, 1449 (1) 8 doi:10.1007/s40278-013-2663-3
(2013) Carbamazepine overdose. Reactions Weekly, 1449 (1) 9 doi:10.1007/s40278-013-2664-2
(2013) Candesartan cilexetil/PEG-3350. Reactions Weekly, 1449 (1) 9 doi:10.1007/s40278-013-2665-1
(2013) Carbamazepine. Reactions Weekly, 1449 (1) 9 doi:10.1007/s40278-013-2666-0
(2013) Carbamazepine. Reactions Weekly, 1449 (1) 9 doi:10.1007/s40278-013-2667-z
(2013) Carvedilol. Reactions Weekly, 1449 (1) 10 doi:10.1007/s40278-013-2668-y
(2013) Cefalexin/cefazolin. Reactions Weekly, 1449 (1) 10 doi:10.1007/s40278-013-2669-x
(2013) Ciclosporin. Reactions Weekly, 1449 (1) 10 doi:10.1007/s40278-013-2670-4
(2013) Cefuroxime axetil. Reactions Weekly, 1449 (1) 10 doi:10.1007/s40278-013-2671-3
(2013) Clozapine. Reactions Weekly, 1449 (1) 11 doi:10.1007/s40278-013-2672-2
(2013) Cisplatin/etoposide/ifosfamide. Reactions Weekly, 1449 (1) 11 doi:10.1007/s40278-013-2673-1
(2013) Ciclosporin/imatinib interaction. Reactions Weekly, 1449 (1) 11 doi:10.1007/s40278-013-2674-0
(2013) Clarithromycin/fentanyl interaction. Reactions Weekly, 1449 (1) 11 doi:10.1007/s40278-013-2675-z
(2013) Cocaine. Reactions Weekly, 1449 (1) 12 doi:10.1007/s40278-013-2676-y
(2013) Dacarbazine. Reactions Weekly, 1449 (1) 12 doi:10.1007/s40278-013-2677-x
(2013) Clozapine/olanzapine. Reactions Weekly, 1449 (1) 12 doi:10.1007/s40278-013-2678-9
(2013) Dabigatran etexilate. Reactions Weekly, 1449 (1) 12 doi:10.1007/s40278-013-2679-8
(2013) Dexamethasone/doxorubicin/vincristine. Reactions Weekly, 1449 (1) 13 doi:10.1007/s40278-013-2680-2
(2013) Diazepam/fentanyl. Reactions Weekly, 1449 (1) 13 doi:10.1007/s40278-013-2681-1
(2013) Denosumab/rosuvastatin interaction. Reactions Weekly, 1449 (1) 13 doi:10.1007/s40278-013-2682-0
(2013) Decitabine. Reactions Weekly, 1449 (1) 13 doi:10.1007/s40278-013-2683-z
(2013) Doxorubicin/ifosfamide. Reactions Weekly, 1449 (1) 14 doi:10.1007/s40278-013-2684-y
(2013) Dopamine agonists. Reactions Weekly, 1449 (1) 14 doi:10.1007/s40278-013-2685-x
(2013) Diethylstilbestrol. Reactions Weekly, 1449 (1) 14 doi:10.1007/s40278-013-2686-9
(2013) Duloxetine. Reactions Weekly, 1449 (1) 15 doi:10.1007/s40278-013-2687-8
(2013) Epinephrine/nitroglycerin. Reactions Weekly, 1449 (1) 15 doi:10.1007/s40278-013-2688-7
(2013) Etanercept. Reactions Weekly, 1449 (1) 15 doi:10.1007/s40278-013-2689-6
(2013) Enoxaparin sodium. Reactions Weekly, 1449 (1) 15 doi:10.1007/s40278-013-2690-0
(2013) Fingolimod. Reactions Weekly, 1449 (1) 16 doi:10.1007/s40278-013-2691-z
(2013) Ethinylestradiol/norethisterone. Reactions Weekly, 1449 (1) 16 doi:10.1007/s40278-013-2692-y
(2013) Fentanyl/morphine. Reactions Weekly, 1449 (1) 16 doi:10.1007/s40278-013-2693-x
(2013) Ferrous sulfate overdose. Reactions Weekly, 1449 (1) 16 doi:10.1007/s40278-013-2694-9
(2013) Fluorouracil/oxaliplatin. Reactions Weekly, 1449 (1) 17 doi:10.1007/s40278-013-2695-8
(2013) Heparin. Reactions Weekly, 1449 (1) 17 doi:10.1007/s40278-013-2696-7
(2013) Heparin. Reactions Weekly, 1449 (1) 17 doi:10.1007/s40278-013-2697-6
(2013) Flecainide overdose. Reactions Weekly, 1449 (1) 17 doi:10.1007/s40278-013-2698-5
(2013) Flecainide. Reactions Weekly, 1449 (1) 17 doi:10.1007/s40278-013-2699-4
(2013) Hib-DTaP-poliovirus vaccine. Reactions Weekly, 1449 (1) 18 doi:10.1007/s40278-013-2700-2
(2013) Hydroxychloroquine/methotrexate/prednisone. Reactions Weekly, 1449 (1) 18 doi:10.1007/s40278-013-2701-1
(2013) Hydroxycarbamide. Reactions Weekly, 1449 (1) 18 doi:10.1007/s40278-013-2702-0
(2013) Hydroquinone. Reactions Weekly, 1449 (1) 18 doi:10.1007/s40278-013-2703-z
(2013) Immunosuppressants. Reactions Weekly, 1449 (1) 19 doi:10.1007/s40278-013-2704-y
(2013) Ibuprofen. Reactions Weekly, 1449 (1) 19 doi:10.1007/s40278-013-2705-x
(2013) Immune globulin. Reactions Weekly, 1449 (1) 19 doi:10.1007/s40278-013-2706-9
(2013) Hydroxypropyl betadex. Reactions Weekly, 1449 (1) 19 doi:10.1007/s40278-013-2707-8
(2013) Itraconazole/vincristine interaction. Reactions Weekly, 1449 (1) 20 doi:10.1007/s40278-013-2708-7
(2013) Josamycin. Reactions Weekly, 1449 (1) 20 doi:10.1007/s40278-013-2709-6
(2013) Indometacin. Reactions Weekly, 1449 (1) 20 doi:10.1007/s40278-013-2710-0
(2013) Ipilimumab. Reactions Weekly, 1449 (1) 20 doi:10.1007/s40278-013-2711-z
(2013) Insulin detemir. Reactions Weekly, 1449 (1) 20 doi:10.1007/s40278-013-2712-y
(2013) Lenalidomide. Reactions Weekly, 1449 (1) 21 doi:10.1007/s40278-013-2713-x
(2013) Lansoprazole. Reactions Weekly, 1449 (1) 21 doi:10.1007/s40278-013-2714-9
(2013) Lidocaine/prilocaine. Reactions Weekly, 1449 (1) 21 doi:10.1007/s40278-013-2715-8
(2013) Ketamine abuse. Reactions Weekly, 1449 (1) 21 doi:10.1007/s40278-013-2716-7
(2013) Local anaesthetics. Reactions Weekly, 1449 (1) 22 doi:10.1007/s40278-013-2717-6
(2013) Lithium. Reactions Weekly, 1449 (1) 22 doi:10.1007/s40278-013-2718-5
(2013) Lithium/vitamin D interaction. Reactions Weekly, 1449 (1) 22 doi:10.1007/s40278-013-2719-4
(2013) Measles and rubella virus vaccine. Reactions Weekly, 1449 (1) 23 doi:10.1007/s40278-013-2720-y
(2013) Methotrexate. Reactions Weekly, 1449 (1) 23 doi:10.1007/s40278-013-2721-x
(2013) Loteprednol etabonate. Reactions Weekly, 1449 (1) 23 doi:10.1007/s40278-013-2722-9
(2013) Methylprednisolone/prednisolone. Reactions Weekly, 1449 (1) 24 doi:10.1007/s40278-013-2723-8
(2013) Niacin. Reactions Weekly, 1449 (1) 24 doi:10.1007/s40278-013-2724-7
(2013) Metronidazole. Reactions Weekly, 1449 (1) 24 doi:10.1007/s40278-013-2725-6
(2013) Methotrexate. Reactions Weekly, 1449 (1) 24 doi:10.1007/s40278-013-2726-5
(2013) Nicorandil/ramipril. Reactions Weekly, 1449 (1) 25 doi:10.1007/s40278-013-2727-4
(2013) Ondansetron/propofol. Reactions Weekly, 1449 (1) 25 doi:10.1007/s40278-013-2728-3
(2013) Olanzapine/risperidone. Reactions Weekly, 1449 (1) 25 doi:10.1007/s40278-013-2729-2
(2013) Omeprazole/prasugrel interaction. Reactions Weekly, 1449 (1) 25 doi:10.1007/s40278-013-2730-9
(2013) Peginterferon-α/telaprevir. Reactions Weekly, 1449 (1) 26 doi:10.1007/s40278-013-2731-8
(2013) Peginterferon-α-2a/ribavirin. Reactions Weekly, 1449 (1) 26 doi:10.1007/s40278-013-2732-7
(2013) Oxaliplatin. Reactions Weekly, 1449 (1) 26 doi:10.1007/s40278-013-2733-6
(2013) Phencyclidine. Reactions Weekly, 1449 (1) 26 doi:10.1007/s40278-013-2734-5
(2013) Phenytoin. Reactions Weekly, 1449 (1) 27 doi:10.1007/s40278-013-2735-4
(2013) Phenylephrine. Reactions Weekly, 1449 (1) 27 doi:10.1007/s40278-013-2736-3
(2013) Phenobarbital sodium/phenytoin/valproate semisodium. Reactions Weekly, 1449 (1) 27 doi:10.1007/s40278-013-2737-2
(2013) Phenylephrine. Reactions Weekly, 1449 (1) 27 doi:10.1007/s40278-013-2738-1
(2013) Phenytoin. Reactions Weekly, 1449 (1) 28 doi:10.1007/s40278-013-2739-0
(2013) Prednisolone. Reactions Weekly, 1449 (1) 28 doi:10.1007/s40278-013-2740-7
(2013) Progesterone. Reactions Weekly, 1449 (1) 28 doi:10.1007/s40278-013-2741-6
(2013) Rifampicin. Reactions Weekly, 1449 (1) 29 doi:10.1007/s40278-013-2742-5
(2013) Semagacestat. Reactions Weekly, 1449 (1) 29 doi:10.1007/s40278-013-2743-4
(2013) Ryutan shakan to. Reactions Weekly, 1449 (1) 29 doi:10.1007/s40278-013-2744-3
(2013) Quetiapine. Reactions Weekly, 1449 (1) 29 doi:10.1007/s40278-013-2745-2
(2013) Risperidone. Reactions Weekly, 1449 (1) 29 doi:10.1007/s40278-013-2746-1
(2013) Sulbenicillin/tetanus immune globulin. Reactions Weekly, 1449 (1) 30 doi:10.1007/s40278-013-2747-0
(2013) Sunitinib. Reactions Weekly, 1449 (1) 30 doi:10.1007/s40278-013-2748-z
(2013) Sibutramine. Reactions Weekly, 1449 (1) 30 doi:10.1007/s40278-013-2749-y
(2013) Sorafenib. Reactions Weekly, 1449 (1) 30 doi:10.1007/s40278-013-2750-5
(2013) Tadalafil. Reactions Weekly, 1449 (1) 31 doi:10.1007/s40278-013-2751-4
(2013) Tacrolimus. Reactions Weekly, 1449 (1) 31 doi:10.1007/s40278-013-2752-3
(2013) Temsirolimus. Reactions Weekly, 1449 (1) 31 doi:10.1007/s40278-013-2753-2
(2013) Tenofovir. Reactions Weekly, 1449 (1) 31 doi:10.1007/s40278-013-2754-1
(2013) Valproic acid. Reactions Weekly, 1449 (1) 32 doi:10.1007/s40278-013-2755-0
(2013) Topiramate/zonisamide. Reactions Weekly, 1449 (1) 32 doi:10.1007/s40278-013-2756-z
(2013) Terbinafine. Reactions Weekly, 1449 (1) 32 doi:10.1007/s40278-013-2757-y
(2013) Traditional Chinese medicine. Reactions Weekly, 1449 (1) 32 doi:10.1007/s40278-013-2758-x
(2013) Voriconazole. Reactions Weekly, 1449 (1) 33 doi:10.1007/s40278-013-2759-9
(2013) Zanamivir. Reactions Weekly, 1449 (1) 33 doi:10.1007/s40278-013-2760-3
(2013) Xylometazoline. Reactions Weekly, 1449 (1) 33 doi:10.1007/s40278-013-2761-2
(2013) Ziconotide. Reactions Weekly, 1449 (1) 33 doi:10.1007/s40278-013-2762-1
(2013) Ziprasidone. Reactions Weekly, 1449 (1) 34 doi:10.1007/s40278-013-2763-0
(2013) Zotepine. Reactions Weekly, 1449 (1) 34 doi:10.1007/s40278-013-2764-z

See Also

These are possibly similar items as determined by title/reference text matching only.

(2013, April) Reactions Weekly Vol. 1446 (1) Springer Science and Business Media LLC
(2013, April) Reactions Weekly Vol. 1447 (1) Springer Science and Business Media LLC
(2013, April) Reactions Weekly Vol. 1448 (1) Springer Science and Business Media LLC
(2018, April) Reactions Weekly Vol. 1696 (1) Springer Science and Business Media LLC
(2018, April) Reactions Weekly Vol. 1697 (1) Springer Science and Business Media LLC
(2018, April) Reactions Weekly Vol. 1698 (1) Springer Science and Business Media LLC
(2018, April) Reactions Weekly Vol. 1699 (1) Springer Science and Business Media LLC
(2019, April) Reactions Weekly Vol. 1746 (1) Springer Science and Business Media LLC
(2019, April) Reactions Weekly Vol. 1747 (1) Springer Science and Business Media LLC
(2019, April) Reactions Weekly Vol. 1748 (1) Springer Science and Business Media LLC
(2019, April) Reactions Weekly Vol. 1749 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 15, 2025 21:33:14
Go to top of page